List of Teva Pharmaceutical Industries patents

Patents where

Current Assignee

Name

Teva Pharmaceutical Industries

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11642451 Medical injection device packaging	Patent 11642451 was granted and assigned to Teva Pharmaceutical Industries on May, 2023 by the United States Patent and Trademark Office.	Teva Pharmaceutical Industries	Teva Pharmaceutical Industries	United States Patent and Trademark Office	11642451	May 9, 2023
‌ US Patent 9827374 Re-useable injector device for syringe	Patent 9827374 was granted and assigned to Teva Pharmaceutical Industries on November, 2017 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	9827374	November 28, 2017
‌ US Patent 6881420 Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation	Patent 6881420 was granted and assigned to Teva Pharmaceutical Industries on April, 2005 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	6881420	April 19, 2005
‌ US Patent 6924393 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof	Patent 6924393 was granted and assigned to Teva Pharmaceutical Industries on August, 2005 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	6924393	August 2, 2005
‌ US Patent 11472772 S1P3 antagonists		Teva Pharmaceutical Industries	Teva Pharmaceutical Industries	United States Patent and Trademark Office	11472772	October 18, 2022
‌ US Patent 7056942 Carvedilol	Patent 7056942 was granted and assigned to Teva Pharmaceutical Industries on June, 2006 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	7056942	June 6, 2006
‌ US Patent 7423153 Crystalline forms of gatifloxacin	Patent 7423153 was granted and assigned to Teva Pharmaceutical Industries on September, 2008 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	7423153	September 9, 2008
‌ US Patent 7411067 Crystalline forms of gatifloxacin	Patent 7411067 was granted and assigned to Teva Pharmaceutical Industries on August, 2008 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	7411067	August 12, 2008
‌ US Patent 7071331 Synthesis of quetiapine and pharmaceutically acceptable salts thereof	Patent 7071331 was granted and assigned to Teva Pharmaceutical Industries on July, 2006 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	7071331	July 4, 2006
‌ US Patent 8993519 Method of treatment for neutropenia using stable formulations of recombinant human albumin-human granulocyte colony stimulating factor	Patent 8993519 was granted and assigned to Teva Pharmaceutical Industries on March, 2015 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	8993519	March 31, 2015
‌ US Patent 8323634 Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor	Patent 8323634 was granted and assigned to Teva Pharmaceutical Industries on December, 2012 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	8323634	December 4, 2012
‌ US Patent D745664 Injector device for a syringe			Teva Pharmaceutical Industries	United States Patent and Trademark Office	D745664	December 15, 2015
‌ US Patent 10071206 Re-useable injector device for syringe	Patent 10071206 was granted and assigned to Teva Pharmaceutical Industries on September, 2018 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	10071206	September 11, 2018
‌ US Patent 6936720 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide	Patent 6936720 was granted and assigned to Teva Pharmaceutical Industries on August, 2005 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	6936720	August 30, 2005
‌ US Patent 7022881 Sertraline hydrochloride polymorphs	Patent 7022881 was granted and assigned to Teva Pharmaceutical Industries on April, 2006 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	7022881	April 4, 2006
‌ US Patent 6987175 Processes for preparing clarithromycin polymorphs	Patent 6987175 was granted and assigned to Teva Pharmaceutical Industries on January, 2006 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	6987175	January 17, 2006
‌ US Patent 7067669 Substantially pure cilostazol and processes for making same	Patent 7067669 was granted and assigned to Teva Pharmaceutical Industries on June, 2006 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	7067669	June 27, 2006
‌ US Patent 6956121 Preparation of paroxetine involving novel intermediates	Patent 6956121 was granted and assigned to Teva Pharmaceutical Industries on October, 2005 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	6956121	October 18, 2005
‌ US Patent 7060837 Method for the purification of lansoprazole	Patent 7060837 was granted and assigned to Teva Pharmaceutical Industries on June, 2006 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	7060837	June 13, 2006
‌ US Patent 6852855 Synthesis of piperazine ring	Patent 6852855 was granted and assigned to Teva Pharmaceutical Industries on February, 2005 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	6852855	February 8, 2005
‌ US Patent 6858652 Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them	Patent 6858652 was granted and assigned to Teva Pharmaceutical Industries on February, 2005 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	6858652	February 22, 2005
‌ US Patent 6861426 Crystal forms of lamotrigine and processes for their preparations	Patent 6861426 was granted and assigned to Teva Pharmaceutical Industries on March, 2005 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	6861426	March 1, 2005
‌ US Patent 6849120 Oxidation method for preparing highly pure modafinil, crystalline forms of modafinil, and methods of preparing the crystalline forms	Patent 6849120 was granted and assigned to Teva Pharmaceutical Industries on February, 2005 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	6849120	February 1, 2005
‌ US Patent 6849736 Crystalline forms of valacyclovir hydrochloride	Patent 6849736 was granted and assigned to Teva Pharmaceutical Industries on February, 2005 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	6849736	February 1, 2005
‌ US Patent 6849737 Synthesis and purification of valacyclovir	Patent 6849737 was granted and assigned to Teva Pharmaceutical Industries on February, 2005 by the United States Patent and Trademark Office.		Teva Pharmaceutical Industries	United States Patent and Trademark Office	6849737	February 1, 2005

Results per page:

43 results

0 selected

43 results

0 selected